Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business

Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment 

FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that the Company completed its previously announced evaluation of strategic alternatives for Tissue Health Plus (“THP”). Following the completion of this evaluation, the Company initiated a strategic realignment of its business, discontinuing operations of THP to improve its operating efficiency and reallocate resources to its core surgical business.

Read more at globenewswire.com